Aalto Bio Reagents Launches World's First Commercially Available
Venezuela Equine Encephalitis Virus (VEEV) Protein.
BARCELONA, SPAIN, JUNE 6, 2019 — On the occasion of the 11th International Global Virus Network meeting, Aalto Bio Reagents launches the first commercially available protein for the detection and diagnosis of Venezuela Equine Encephalitis NSP2 TC83.
